Letter: Thalidomine neuropathy and leprous neuritis.
D003937:Diagnosis, Differential; D006801:Humans; D006987:Hypesthesia / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D007918:Leprosy / Q000150:complications* / Q000382:microbiology; D009166:Mycobacterium leprae / Q000302:isolation & purification; D009443:Neuritis / Q000139:chemically induced / Q000150:complications / Q000175:diagnosis / Q000209:etiology*; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*; D012018:Reflex / Q000187:drug effects; D012677:Sensation; D011984:Sensory Receptor Cells / Q000187:drug effects; D013696:Temperature; D013792:Thalidomide / Q000009:adverse effects* / Q000494:pharmacology
D013792:Thalidomide